
RxRevu, a Denver-based prescription pricing company, has secured $7 million in Series B funding. JAZZ Venture Partners led the round.
Source: Press Release
RxRevu, a Denver-based prescription pricing company, has secured $7 million in Series B funding.
RxRevu, a Denver-based prescription pricing company, has secured $7 million in Series B funding. JAZZ Venture Partners led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination